Utility of stromal lymphocytes in diagnosis and predicting upgrade of B3 breast lesions from core biopsies
T. Kader, S. Hendry, E. Provenzano, M. W. Jayawardana, J.-M. Pang, K. Elder, D. J. Byrne, L. Tjoeka, H. M. Frazer, E. House, S. Jayasinghe, H. Keane, A. Murugasu, N. Rajan, I. M. Miligy, , K. L. Gorringe
This study identifies stromal lymphocytes as a biomarker to predict upgrade of B3 breast lesions from core biopsies, with high specificity.
bioRxiv · Sep 2, 2022 · PreprintCancer Biology